Niva Bupa Health Insurance Company Limited has informed the Exchange about Investor Presentation
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Niva Bupa shared its FY2025 investor presentation following its earnings call on May 7, 2025. Gross Written Premium (without 1/n) grew 32% YoY to ₹7,407 crore, while reported GWP (with 1/n) grew 21% to ₹6,762 crore — the difference is due to an IRDAI mandate from October 2024 requiring long-term products to be accounted on a 1/n basis. Profit After Tax (I-GAAP) jumped 161% to ₹213.5 crore, with IFRS PAT up 91% to ₹203.3 crore. Underlying combined ratio improved by 330 bps to 96.1% (without 1/n), though reported combined ratio rose to 101.2%. Retail health market share expanded to 9.4% from 9.1%, claims settlement ratio improved to 92.4%, and AUM grew to ₹8,175 crore. Solvency ratio stood strong at 3.03x with ROAE at 8.4%.
Strong showing for shareholders — robust premium growth, sharp jump in profitability, and expanding retail market share reinforce Niva Bupa's growth story. The reported combined ratio crossing 100% (due to a regulatory accounting change, not business deterioration) may draw short-term scrutiny, but the underlying profitability trend remains firmly positive.